» Articles » PMID: 20188160

Protein Aggregation--pathways and Influencing Factors

Overview
Journal Int J Pharm
Specialties Chemistry
Pharmacology
Date 2010 Mar 2
PMID 20188160
Citations 154
Authors
Affiliations
Soon will be listed here.
Abstract

Proteins generally will tend to aggregate under a variety of environmental conditions in comparison with small drug molecules. The extent of aggregation is dependent on many factors that can be broadly classified as intrinsic (primary, secondary, tertiary or quaternary structure) or extrinsic (environment in which protein is present, processing conditions, etc). These protein aggregates may exhibit less desirable characteristics like reduced or no biological activity, potential for immunogenicity or other side effects. Protein aggregation remains one of the major challenges in the development and commercialization of biotechnology products. This article is intended to review and discuss the latest understandings in protein aggregation pathways and the possible extrinsic factors that affect or control the protein aggregation process.

Citing Articles

Ionic liquids as stabilisers of therapeutic protein formulations: a review of insulin and monoclonal antibodies.

Tien S, Kayser V Biophys Rev. 2025; 17(1):89-101.

PMID: 40060006 PMC: 11885717. DOI: 10.1007/s12551-024-01261-y.


The influence of a dicationic surfactant on the aggregation process of the IVAGVN peptide derived from the human cystatin C sequence (56-61).

Ludwiczak J, Ilowska E, Wilkowska M, Szymanska A, Kempka M, Dobies M RSC Adv. 2025; 15(5):3237-3249.

PMID: 39896427 PMC: 11784886. DOI: 10.1039/d4ra08377f.


Beyond Misfolding: A New Paradigm for the Relationship Between Protein Folding and Aggregation.

Choi S, Jin Y, Choi Y, Seong B Int J Mol Sci. 2025; 26(1.

PMID: 39795912 PMC: 11720324. DOI: 10.3390/ijms26010053.


Silk fibroin-based hydrogels for cartilage organoids in osteoarthritis treatment.

Shen C, Zhou Z, Li R, Yang S, Zhou D, Zhou F Theranostics. 2025; 15(2):560-584.

PMID: 39744693 PMC: 11671376. DOI: 10.7150/thno.103491.


Antibody Aggregation: A Problem Within the Biopharmaceutical Industry and Its Role in AL Amyloidosis Disease.

Sheehan K, Jeon H, Corr S, Hayes J, Mok K Protein J. 2024; 44(1):1-20.

PMID: 39527351 DOI: 10.1007/s10930-024-10237-6.